Question 1

What are the potential heart risks of using LABAs for my asthma or COPD?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction clinical trial (NCT01636726). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this study's findings relate to my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction clinical trial (NCT01636726). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there alternative treatments that might have fewer risks?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction clinical trial (NCT01636726). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I monitor while using LABAs to ensure my heart health is not affected?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction clinical trial (NCT01636726). Contact the study team or your healthcare provider for specific answers.

Question 5

How can I participate in studies like this in the future?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction clinical trial (NCT01636726). Contact the study team or your healthcare provider for specific answers.

What this study is about